SMYD2 and metabolic dysfunction-associated steatotic liver disease: Surprisingly, knockout of Tbx3 (transcription factors) and Smyd2 (epigenetic factor) resulted in the most significant reduction of liver injury and steatosis, even though Tbx3 and Smyd2 have not been linked to NAFLD/NASH pathogenesis before.